Bicara Therapeutics (BCAX) Q1 2025 Earnings
BCAX·Reported May 13, 2025·Before market open
Diluted EPS came in at $-0.68 (-149.3% YoY), missed the $-0.40 consensus by $0.28.
Diluted EPS
$-0.68missed by $0.28
Consensus: $-0.40
Financial Snapshot
Trailing eight quarters through Q1 2025
Q1 2025 Earnings FAQ
Common questions about Bicara Therapeutics's Q1 2025 earnings report.
Bicara Therapeutics (BCAX) reported Q1 2025 earnings on May 13, 2025 before market open.
Bicara Therapeutics reported diluted EPS of $-0.68 for Q1 2025.
EPS missed the consensus estimate of $-0.40 by $0.28.
Compared to the same quarter a year prior, diluted EPS declined 149.3% from $-0.27.
You can read the 10-Q periodic report (0002023658-25-000039) directly on SEC EDGAR. The filing index links above go to sec.gov.